• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

UCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power Care

Share:

July 22, 2019

Doctor working on a virtual screen. medical technology concept

DEARhealth, a health IT spin-out from the College of California, Los Angeles (UCLA) has raised $6.eight million
in Collection A funding to develop its AI-powered pathway platform for continual care.

Contributors within the Collection A funding spherical embrace Philips Well being Know-how
Ventures, Vesalius Biocapital III and Well being Improvements.

DEARhealth was based in 2011 by Daniel Hommes as a analysis mission when a staff of UCLA specialists
designed a value-based care program for the administration of continual illnesses and
efficiently examined it in Inflammatory Bowel Illnesses (IBD), a set of
prototypic continual and extremely advanced illnesses sometimes related to poor
well being outcomes and excessive prices. . The aim was to check if data-driven care
planning for individuals with continual illnesses may have higher outcomes, improved
experiences with decrease price (Triple Goal goal). Hommes, now Chief Government
Officer at DEARhealth: “Within the first prototypes for Inflammatory Bowel Illness
(IBD), we demonstrated that the illness relapse price in addition to ED visits and
hospitalizations had been considerably decreased. This additionally had a huge effect on
projected prices.“

DEARhealth provides Artificial
Intelligence (AI)-powered well being pathways for continual care, together with ache
administration, liver illnesses, ovarian most cancers, continual kidney illnesses, low again
ache and epilepsy. Primarily based on the mannequin, the software program optimizes each day care
supply by constantly presenting suggestions derived from superior
skilled algorithms and deep studying outcomes. Suppliers will be capable of settle for
or decline these suggestions in order that over time, via machine-learning,
suppliers’ selections will develop into optimally aligned with Triple Goal outcomes.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Affected person-Reported Knowledge & Outcomes

Each patient-reported
outcomes and information derived from medical gadgets will assist increase the learnings.
Through cell apps, sufferers and their caregivers are engaged to actively
take part of their care pathway and its further supervised modules for
adherence, psychological assist, dietary assist, wellness and training.

The DEARhealth platform
seamlessly integrates its clever healthcare pathways to current
Digital Medical Report methods (EMR). Suppliers are engaged via an EMR
built-in utility layer during which they’re invited to handle their sufferers
and effectively shift duties between specialist, major care doctor, care
coordinator or case-manager.

Plans for Funding

DEARhealth will use the newest spherical of funding to scale the testing of its well being expertise providing to extra hospitals, thus considerably enhancing Worth-Primarily based Well being Care Administration. As well as, DEARhealth will develop operations to Europe, opening their European headquarters in Amsterdam, The Netherlands.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Enlyt Health Secures $10M to Expand Healthcare Digital Front DoorEnlyt Health Secures $10M to Expand Healthcare Digital Front Door
  • Osso VR Brings Film Industry Level Quality VR Surgical Training to OROsso VR Brings Film Industry Level Quality VR Surgical Training to OR
  • Voro Raises $2.5M To Bring Trusted Reviews And Referrals Of DoctorsVoro Raises $2.5M To Bring Trusted Reviews And Referrals Of Doctors
  • Chinese Startup Gets CE Mark for AI Polyp Detection ToolChinese Startup Gets CE Mark for AI Polyp Detection Tool
  • Trust in health sector takes a hit in major markets, Edelman research findsTrust in health sector takes a hit in major markets, Edelman research finds
  • Omega Healthcare Investors to Acquire MedEquities Realty TrustOmega Healthcare Investors to Acquire MedEquities Realty Trust
  • US Radiology Acquires ImageSouth, Expanding National Radiology FootprintUS Radiology Acquires ImageSouth, Expanding National Radiology Footprint
  • Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for PregnancyBabyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications